Literature DB >> 18442631

Intensive blood glucose control in acute and prolonged critical illness: endogenous secretion contributes more to plasma insulin than exogenous insulin infusion.

Frantisek Duska1, Michal Andel.   

Abstract

We investigated the contribution of impaired insulin secretion (observed as dynamics of C-peptide) and insulin resistance (measured by euglycemic clamps) to glucose dysregulation in 20 critically ill patients after severe trauma during feeding and intensive glucose control with intravenous insulin. Between the fourth and seventh day when insulin sensitivity is lowest, insulin secretion is highest and supranormal despite tight control of blood glucose by exogenous insulin. Afterward, plasma C-peptide decreases together with an improvement in insulin sensitivity. Multiple regression analysis revealed that plasma insulin is determined more by endogenous secretion than insulin infusion, even during the acute phase when exogenous insulin requirements are high.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442631     DOI: 10.1016/j.metabol.2008.01.001

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Intermediary variables and algorithm parameters for an electronic algorithm for intravenous insulin infusion.

Authors:  Susan S Braithwaite; Hemant Godara; Julie Song; Bruce A Cairns; Samuel W Jones; Guillermo E Umpierrez
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

2.  Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation.

Authors:  Alexander Koch; Ralf Weiskirchen; Edouard Sanson; Henning W Zimmermann; Sebastian Voigt; Hanna Dückers; Christian Trautwein; Frank Tacke
Journal:  Crit Care       Date:  2010-10-08       Impact factor: 9.097

3.  Prevalence of ketosis, ketonuria, and ketoacidosis during liberal glycemic control in critically ill patients with diabetes: an observational study.

Authors:  Nora Luethi; Luca Cioccari; Marco Crisman; Rinaldo Bellomo; Glenn M Eastwood; Johan Mårtensson
Journal:  Crit Care       Date:  2016-09-15       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.